Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹1,827 Cr₹1,505 Cr₹1,273 Cr₹1,168 Cr₹2,009 Cr

What is the latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,827 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹1,827 Cr
Mar2025₹1,505 Cr
Mar2024₹1,273 Cr
Mar2023₹1,168 Cr
Mar2022₹2,009 Cr

How is Net Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2026 ₹1,827 Cr
21.42
Mar2025 ₹1,505 Cr
18.16
Mar2024 ₹1,273 Cr
9.04
Mar2023 ₹1,168 Cr
-41.88
Mar2022 ₹2,009 Cr -

Compare Net Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹46,185.2 Cr 9% 7.7% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

9%

7.7%

4.2%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses